Żołnierek, J. “The First Line Therapy for Intermediate/ High Risk Patients With Advanced Renal Cell Carcinoma According to Therapeutic Program B.10”. OncoReview, Vol. 13, no. 2(50), Aug. 2023, pp. 48-57, doi:10.24292/01.OR.132190823.